TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma
Curated by ChEMBL
Boehringer Ingelheim Pharma
Curated by ChEMBL
Affinity DataEC50: 21nMAssay Description:Agonist activity at human GPR119 expressed in MIN6 cells assessed as intracellular cAMP level after 45 mins by ALPHAscreen cAMP assayMore data for this Ligand-Target Pair
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma
Curated by ChEMBL
Boehringer Ingelheim Pharma
Curated by ChEMBL
Affinity DataEC50: 800nMAssay Description:Agonist activity at human GPR119 expressed in MIN6 cells assessed as intracellular cAMP level after 45 mins by ALPHAscreen cAMP assayMore data for this Ligand-Target Pair
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma
Curated by ChEMBL
Boehringer Ingelheim Pharma
Curated by ChEMBL
Affinity DataEC50: 93nMAssay Description:Agonist activity at human GPR119 expressed in MIN6 cells assessed as intracellular cAMP level after 45 mins by ALPHAscreen cAMP assayMore data for this Ligand-Target Pair
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma
Curated by ChEMBL
Boehringer Ingelheim Pharma
Curated by ChEMBL
Affinity DataEC50: 30nMAssay Description:Agonist activity at human GPR119 expressed in MIN6 cells assessed as intracellular cAMP level after 45 mins by ALPHAscreen cAMP assayMore data for this Ligand-Target Pair